Infections and systemic lupus erythematosus: Binding or sparring partners?

International Journal of Molecular Sciences

Volumn 16, Issue 8, 2015, Pages 17331-17343

  Rigante, Donato ^a   Esposito, Susanna ^b  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Cytomegalovirus; Epstein Barr virus; Parvovirus B19; Retrovirus; Systemic lupus erythematosus

Indexed keywords

AUTOIMMUNITY; EPSTEIN BARR VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INFECTION; MACROPHAGE ACTIVATION SYNDROME; NONHUMAN; PARVOVIRUS INFECTION; PATHOGENESIS; PREVALENCE; PROTEIN EXPRESSION; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TOXOPLASMOSIS; ANIMAL; COMPLICATION; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LUPUS ERYTHEMATOSUS, SYSTEMIC; VIROLOGY; VIRUS INFECTION;

ANIMALIA; CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 4; PARVOVIRUS; PROTOZOA;

ANIMALS; AUTOIMMUNITY; HOST-PATHOGEN INTERACTIONS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; VIRUS DISEASES;

EID: 84938349011     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms160817331     Document Type: Review

References (65)

1. Arbuckle, M. R.; McClain, M. T.; Rubertone, M. V.; Scofield, R. H.; Dennis, G. J.; James, J. A.; Harley, J. B. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 2003, 349, 1526-1533.
2. Taddio, A.; Rossetto, E.; Rosé, C. D.; Brescia, A. M.; Bracaglia, C.; Cortis, E.; Rigante, D.; Stabile, A.; Montico, M.; Ronfani, L.; et al. Prognostic impact of atypical presentation in pediatric systemic lupus erythematosus: Results from a multicenter study. J. Pediatr. 2010, 156, 972-977.
3. Habibi, S.; Saleem, M. A.; Ramanan, A. V. Juvenile systemic lupus erythematosus: Review of clinical features and management. Indian Pediatr. 2011, 48, 879-887.
4. Tan, E. M.; Cohen, A. S.; Fries, J. F.; Masi, A. T.; McShane, D. J.; Rothfield, N. F.; Schaller, J. G.; Talal, N.; Winchester, R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982, 25, 1271-1277.
5. Petri, M.; Orbai, A. M.; Alarcòn, G. S.; Gordon, C.; Merrill, J. T.; Fortin, P. R.; Bruce, I. N.; Isenberg, D.; Wallace, D. J.; Nived, O.; et al. Derivation and validation of the systemic lupus erythematosus. International collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012, 64, 2677-2686.
6. Doria, A.; Iaccarino, L.; Ghirardello, A.; Zampieri, S.; Arienti, S.; Sarzi-Puttini, P.; Atzeni, F.; Piccoli, A.; Todesco, S. Long-term prognosis and causes of death in systemic lupus erythematosus. Am. J. Med. 2006, 119, 700-706.
7. Brunner, H. I.; Gladman, D. D.; Ibañez, D.; Urowitz, M. D.; Silverman, E. D. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum. 2008, 58, 556-562.
8. Rigante, D.; Mazzoni, M. B.; Esposito, S. The cryptic interplay between systemic lupus erythematosus and infections. Autoimmun. Rev. 2014, 13, 96-102.
9. Rose, N. R.; Mackay, I. R. Molecular mimicry: A critical look at exemplary instances in human diseases. Cell. Mol. Life Sci. 2000, 57, 542-551.
10. Esposito, S.; Bosis, S.; Semino, M.; Rigante, D. Infections and systemic lupus erythematosus. Eur. J. Clin. Microbiol. Infect. Dis. 2014, 33, 1467-1475.
11. Cress, B. F.; Englaender, J. A.; He, W.; Kasper, D.; Linhardt, R. J.; Koffas, M. A. Masquerading microbial pathogens: Capsular polysaccharides mimic host-tissue molecules. FEMS Microbiol. Rev. 2014, 38, 660-697.
12. Esposito, S.; Bianchini, S.; Fastiggi, M.; Fumagalli, M.; Andreozzi, L.; Rigante, D. Geoepidemiological hints about Streptococcus pyogenes strains in relationship with acute rheumatic fever. Autoimmun. Rev. 2015, 14, 616-621.
13. Zandman-Goddard, G.; Berkun, Y.; Barzilai, O.; Boaz, M.; Blank, M.; Ram, M.; Sherer, Y.; Anaya, J. M.; Shoenfeld, Y. Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus disease. Ann. N. Y. Acad. Sci. 2009, 1173, 658-663.
14. James, J. A.; Neas, B. R.; Moser, K. L.; Hall, T.; Bruner, G. R.; Sestak, A. L.; Harley, J. B. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum. 2001, 44, 1122-1126.
15. Toussirot, E.; Roudier, J. Epstein-Barr virus in autoimmune diseases. Best Pract. Res. Clin. Rheumatol. 2008, 22, 883-896.
16. Niller, H. H.; Wolf, H.; Minarovits, J. Regulation and dysregulation of Epstein-Barr virus latency: Implications for the development of autoimmune diseases. Autoimmunity 2008, 41, 298-328.
17. Lu, J. J.; Chen, D. Y.; Hsieh, C. W.; Lan, J. L.; Lin, F. J.; Lin, S. H. Association of Epstein-Barr virus infection with systemic lupus erythematosus in Taiwan. Lupus 2007, 16, 168-175.
18. Pender, M. P. Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. Trends Immunol. 2003, 24, 584-587.
19. Harley, J. B.; James, J. A. Epstein-Barr virus infection induces lupus autoimmunity. Bull. NYU Hosp. Jt. Dis. 2006, 64, 45-50.
20. James, J. A.; Kaufman, K. M.; Farris, A. D.; Taylor-Albert, E.; Lehman, T. J.; Harley, J. B. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J. Clin. Investig. 1997, 100, 3019-3026.
21. Kang, I.; Quan, T.; Nolasco, H. T.; Park, S. H.; Hong, M. S.; Crouch, J.; Pamer, E. G.; Howe, J. G.; Craft, J. Defective control of latent Epstein-Bar virus infection in systemic lupus erythematosus. J. Immunol. 2004, 172, 1287-1294.
22. Niller, H. H.; Wolf, H.; Ay, E.; Minarovits, J. Epigenetic dysregulation of Epstein-Barr virus latency and development of autoimmune disease. Adv. Exp. Med. Biol. 2011, 711, 82-102.
23. Poole, B. D.; Templeton, A. K.; Guthridge, J. M.; Brown, E. J.; Harley, J. B.; James, J. A. Aberrant Epstein-Barr viral infection in systemic lupus erythematosus. Autoimmun. Rev. 2009, 8, 337-342.
24. James, J. A.; Scofield, R. H.; Harley, J. B. Lupus humoral autoimmunity after short peptide immunization. Ann. N. Y. Acad. Sci. 1997, 815, 124-127.
25. Sundar, K.; Jacques, S.; Gottlieb, P.; Villars, R.; Benito, M. E.; Taylor, D. K.; Spatz, L. A. Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and anti-Sm Abs. J. Autoimmun. 2004, 23, 127-140.
26. Poole, B. D.; Gross, T.; Maier, S.; Harley, J. B.; James, J. A. Lupus-like autoantibody development in rabbits and mice after immunization with EBNA-1 fragments. J. Autoimmun. 2008, 31, 362-371.
27. Stathopoulou, E. A.; Routsias, J. G.; Stea, E. A.; Moutsopoulos, H. M.; Tzioufas, A. G. Cross-reaction between Abs to the major epitope of Ro60 kD autoantigen and a homologous peptide of Coxsackie virus 2B protein. Clin. Exp. Immunol. 2005, 141, 148-154.
28. Aslanidis, S.; Pyrpasopoulou, A.; Kontotasios, K.; Doumas, S.; Zamboulis, C. Parvovirus B19 infection and systemic lupus erythematosus: Activation of aberrant pathway? Eur. J. Int. Med. 2008, 19, 314-318.
29. Pavlovic, M.; Kats, A.; Cavallo, M.; Shoenfeld, Y. Clinical and molecular evidence for association of SLE with parvovirus B19. Lupus 2010, 19, 783-792.
30. Tzang, B. S.; Tsay, G. J.; Lee, Y. J.; Li, C.; Sun, Y. S.; Hsu, T. C. The association of VP1 unique region protein in acute parvovirus B19 infection and anti-phospholipid antibody production. Clin. Chim. Acta 2007, 378, 59-65.
31. Tzang, B. S.; Lee, Y. J.; Yang, T. P.; Tsay, G. J.; Shi, J. Y.; Tsai, C. C.; Hsu, T. C. Induction of antiphospholipid antibodies and antiphospholipid syndrome-like autoimmunity in naive mice with antibody against human parvovirus B19 VP1 unique region protein. Clin. Chim. Acta 2007, 382, 31-36.
32. Tzang, B. S.; Lin, T. M.; Tsai, C. C.; Hsu, J. D.; Yang, L. C.; Hsu, T. C. Increased cardiac injury in NZB/W F1 mice received antibody against human parvovirus B19 VP1 unique region protein. Mol. Immunol. 2011, 48, 1518-1524.
33. Hayashi, T.; Lee, S.; Ogasawara, H.; Sekigawa, I.; Iida, N.; Tomino, Y.; Hashimoto, H.; Hirose, S. Exacerbation of systemic lupus erythematosus related to cytomegalovirus infection. Lupus 1998, 7, 561-564.
34. Nawata, M.; Seta, N.; Yamada, M.; Sekigawa, I.; Lida, N.; Hashimoto, H. Possible triggering effect of cytomegalovirus infection on systemic lupus erythematosus. Scand. J. Rheumatol. 2001, 30, 360-362.
35. Stratta, P.; Canavese, C.; Ciccone, G.; Santi, S.; Quaglia, M.; Ghisetti, V.; Marchiaro, G.; Barbui, A.; Fop, F.; Cavallo, R.; et al. Correlation between cytomegalovirus infection and Reynaud's phenomenon in lupus nephritis. Nephron 1999, 82, 145-154.
36. Tugnet, N.; Rylance, P.; Roden, D.; Trela, M.; Nelson, P. Human endogenous retroviruses (HERVs) and autoimmune rheumatic disease: Is there a link? Open Rheumatol. J. 2013, 7, 13-21.
37. Perl, A.; Colombo, E.; Dai, H.; Agarwal, R.; Mark, K. A.; Banki, K.; Poiesz, B. J.; Phillips, P. E.; Hoch, S. O.; Reveille, J. D.; et al. Antibody reactivity to the HRES-1 endogenous retroviral element identifies a subset of patients with systemic lupus erythematosus and overlap syndromes. Correlation with antinuclear antibodies and HLA class II alleles. Arthritis Rheum. 1995, 38, 1660-1671.
38. Pullmann, R.; Bonilla, E.; Phillips, P. E.; Middleton, F. A.; Perl, A. Haplotypes of the HRES-1 endogenous retrovirus are associated with development and disease manifestations of systemic lupus erythematosus. Arthritis Rheum. 2008, 58, 532-540.
39. Carugati, M.; Franzetti, M.; Torre, A.; Giorgi, R.; Genderini, A.; Strambio de Castilla, F.; Gervasoni, C.; Riva, A. Systemic lupus erythematosus and HIV infection: A whimsical relationship. Reports of two cases and review of the literature. Clin. Rheumatol. 2013, 32, 1399-1405.
40. Ramos-Casals, M.; Font, J.; García-Carrasco, M.; Cervera, R.; Jiménez, S.; Trejo, O.; Jiménez, S.; Trejo, O.; de la Red, G.; Sánchez-Tapias, J. M.; et al. Hepatitis C virus infection mimicking systemic lupus erythematosus: Study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus. Arthritis Rheum. 2000, 43, 2801-2806.
41. Tzang, B. S.; Chen, T. Y.; Hsu, T. C.; Liu, Y. C., Tsay, G. J. Presentation of autoantibody to proliferating cell nuclear antigen in patients with chronic hepatitis B and C virus infection. Ann. Rheum. Dis. 1999, 58, 630-634.
42. Shoenfeld, Y.; Vilner, Y.; Coates, A. R.; Rauch, J.; Lavie, G.; Shaul, D.; Pinkhas, J. Monoclonal anti-tuberculosis Abs react with DNA, and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis. Clin. Exp. Immunol. 1986, 66, 255-261.
43. George, J.; Shoenfeld, Y. Infections, idiotypes and SLE. Lupus 1995, 4, 333-335.
44. Pisetsky, D. S. The role of innate immunity in the induction of autoimmunity. Autoimmun. Rev. 2008, 8, 69-72.
45. Corthésy, B. Role of secretory IgA in infection and maintenance of homeostasis. Autoimmun. Rev. 2013, 12, 661-665.
46. Kim, W. U.; Sreih, A.; Bucala, R. Toll-like receptors in systemic lupus erythematosus; prospects for therapeutic intervention. Autoimmun. Rev. 2009, 8, 204-208.
47. Aguiar, C. L.; Soybilgic, A.; Avcin, T.; Myones, B. L. Pediatric antiphospholipid syndrome. Curr. Rheumatol. Rep. 2015, 17, doi: 10. 1007/s11926-015-0504-5.
48. Stabile, A.; Bertoni, B.; Ansuini, V.; la Torraca, I.; Sallì, A.; Rigante, D. The clinical spectrum and treatment options of macrophage activation syndrome in the pediatric age. Eur. Rev. Med. Pharmacol. Sci. 2006, 10, 53-59.
49. Blank, M.; Asherson, R. A.; Cervera, R.; Shoenfeld, Y. Antiphospholipid syndrome infectious origin. J. Clin. Immunol. 2004, 24, 12-23.
50. Ansuini, V.; Rigante, D.; Esposito, S. Debate around infection-dependent hemophagocytic syndrome in paediatrics. BMC Infect. Dis. 2013, 13, doi: 10. 1186/1471-2334-13-15.
51. Praprotnik, S.; Sodin-Semrl, S.; Tomsic, M.; Shoenfeld, Y. The curiously suspicious: Infectious disease may ameliorate an ongoing autoimmune destruction in systemic lupus erythematosus patients. J. Autoimm. 2008, 30, 37-41.
52. Sotgiu, S.; Angius, A.; Embry, A.; Rosai, G.; Musumeci, S. Hygiene hypothesis: Innate immunity, malaria, and multiple sclerosis. Med. Hypotheses 2008, 70, 819-825.
53. Finlay, B. B.; McFadden, G. Anti-immunology: Evasion of the host immune system by bacterial and viral pathogens. Cell 2006, 124, 767-782.
54. Zandman-Goddard, G.; Shoenfeld, Y. Parasitic infection and autoimmunity. Lupus 2009, 18, 1144-1148.
55. Chen, M.; Aosai, F.; Norose, K.; Mun, H. S.; Ishikura, H.; Hirose, S.; Piao, L. X.; Fang, H.; Yano, A. Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black × New Zealand White) F1 mice. Int. Immunol. 2004, 16, 937-946.
56. Fischer, S.; Agmon-Levin, N.; Shapira, Y.; Porat Katz, B. S.; Graell, E.; Cervera, R.; Stojanovich, L.; Gómez Puerta, J. A.; Sanmartí, R.; Shoenfeld, Y.; et al. Toxoplasma gondii: Bystander or cofactor in rheumatoid arthritis. Immunol. Res. 2013, 56, 287-292.
57. Clatworthy, M. R.; Willcocks, L.; Urban, B.; Langhorne, J.; Williams, T. N.; Peshu, N.; Watkins, N. A.; Floto, R. A.; Smith, K. G. Systemic lupus erythematosus-associated defects in the inhibitory receptor FcγRIIb reduce susceptibility to malaria. Proc. Natl. Acad. Sci. USA 2007, 104, 7169-7174.
58. Harnett, W.; Harnett, M. M. Molecular basis of worm-induced immunomodulation. Parasite Immunol. 2006, 28, 535-543.
59. Sawalha, A. H.; Schmid, W. R.; Binder, S. R.; Bacino, D. K.; Harley, J. B. Association between systemic lupus erythematosus and Helicobacter pylori seronegativity. J. Rheumatol. 2004, 3, 1546-1550.
60. Ram, M.; Anaya, J. M.; Barzilai, O.; Izhaky, D.; Porat Katz, B. S.; Blank, M.; Shoenfeld, Y. The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders. Autoimmun. Rev. 2008, 7, 621-625.
61. Esposito, S.; Prada, E.; Mastrolia, M. V.; Tarantino, G.; Codecà, C.; Rigante, D. Autoimmune/inflammatory syndrome induced by adjuvants (ASIA): Clues and pitfalls in the pediatric background. Immunol. Res. 2014, 60, 366-375.
62. Shoenfeld, Y.; Aron-Maor, A. Vaccination and autoimmunity-"vaccinosis": A dangerous liaison? J. Autoimmun. 2000, 14, 1-10.
63. Grimaldi-Bensouda, L.; le Guern, V.; Kone-Paut, I.; Aubrun, E.; Fain, O.; Ruel, M.; Machet, L.; Viallard, J. F.; Magy-Bertrand, N.; Daugas, E.; et al. The risk of systemic lupus erythematosus associated with vaccines: An international case-control study. Arthritis Rheumatol. 2014, 66, 1559-1567.
64. Soybilgic, A.; Onel, K. B.; Utset, T.; Alexander, K.; Wagner-Weiner, L. Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 years. Pediatr. Rheumatol. Online J. 2013, 11, doi: 10. 1186/1546-0096-11-29.
65. Agmon-Levin, N.; Arango, M. T.; Kivity, S.; Katzav, A.; Gilburd, B.; Blank, M.; Tomer, N.; Volkov, A.; Barshack, I.; Chapman, J.; et al. Immunization with hepatitis B vaccine accelerates SLE-like disease in a murine model. J. Autoimmun. 2014, 54, 21-32.